Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1146-1155

  Rasmusscn, Lucy ^a   Zipeto, Donato ^b   Wolitz, Richard A ^c   Dowling, Anna ^c   Efron, Bradley ^c   Merigan, Thomas C ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT PASTEUR   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CYTOMEGALOVIRUS; FEMALE; GENE AMPLIFICATION; HIGH RISK POPULATION; HUMAN; IMMEDIATE EARLY GENE; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETINITIS; RISK ASSESSMENT; VIRUS ISOLATION;

EID: 0030731429     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514106     Document Type: Article

References (30)

1. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
2. Hoover D, Saah A, Bacellar H, et al. Clinical manifestations of AIDS in the era of pncumocystis prophylaxis. N Engl J Med 1993;329:1922-6.
3. Jacobson M, Kramer F, Pavan P, et al. Failure of highly active antiretroviral therapy (HAART) to prevent CMV retinitis despite marked CD4 count increase [abstract 353]. In: 4th Conference on Retro viruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
4. Gilquin J, Piketty C, Thomas V, Gonzales-Canali G, Kazatchkine M. Acute CMV infection in AIDS patients receiving combination therapy including protease inhibitors [abstract 354]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
5. Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 1995;9:471-7.
6. Spector SA, McKinley OF, Lalezari JP, et al. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996;334:1491-7.
7. + T-lymphocyte counts of patients infected with human immunodeficiency virus. J Infect Dis 1995;21:1121-5.
8. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996;114:821-7.
9. Gerdes JC, Specs EK, Fitting K, et al. Prospective study utilizing a quantitative polymerase chain reaction for detection of cytomegalovirus DNA in the blood of renal transplant patients. Transplant Proc 1993;25:1411-3.
10. Gema G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994;32:2707-17.
11. Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992;30:2359-65.
12. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995;33:2607-11.
13. Rasmussen L, Morris S, Zipeto D, et al. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995;171:177-82.
14. Shinkai M, Bozzette S, Powderly W, Frame P, Spector S. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis 1997;175:302-8.
15. Sokal R, Rohlf FJ. Biometry. 2nd ed. San Francisco: WH Freeman, 1981.
16. Efron B, Tibshirani RJ. An introduction to the bootstrap. Monographs on statistics and applied probability. New York: Chapman and Hall, 1993.
17. Moore RD, Keruly JC, Chaisson RE. Duration of the survival benefit of zidovudine therapy in HIV infection. Arch Intern Med 1996;156:1073-7.
18. Pincus MR. Interpreting laboratory results: reference values and decision making. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. 19 ed. Philadelphia: WB Saunders, 1996:74-91.
19. Greene W. Predicting progression to AIDS. Ann Intern Med 1995;123:726-7.
20. Havlir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 1996;124:984-94.
21. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996;174:184-7.
22. Cleaves C, Smith T, Schuster E, Pearson G. Comparison of standard tube culture and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217-21.
23. + lymphocyte counts below 100/microliter of blood: features and relation to risk of subsequent CMV retinitis. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:324-30.
24. Zurlo JJ, O'Neill D, Polis MA, et al. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med 1993;118:12-7.
25. Bitsch A, Kirchner H, Dupke R, Bein G. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J Infect Dis 1993;167:740-3.
26. Boivin G, Olson CA, Quirk MR, Kringstad B, Hertz MI, Jordan MC. Quantitation of Cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis. J Infect Dis 1996;173:1304-12.
27. Gozlan J, Laporte J, Lesage S, et al. Monitoring of Cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol 1996;34:2085-8.
28. Rand KH, Merigan TC. Cytomegalovirus: a not so innocent bystander [editorial]. JAMA 1978;240:2470-1.
29. van den Berg AP, Klompmaker IJ, Haagsma EB, et al. Evidence for an increased rate of bacterial infections in liver transplant patients with Cytomegalovirus infection. Clin Transplant 1996;10:224-31.
30. Salmon D, Lacassin F, Harzic M, et al. Predictive value of Cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol 1990;32:160-3.